Equatorial Guinea vs Lebanon: Prevalence rate of hypertension in adults aged 30-79
Equatorial Guinea
38.1
in 2019
Lebanon
38.1
in 2019
Equatorial Guinea rank
96th
Lebanon rank
96th
Prevalence rate of hypertension in adults aged 30-79 over time
- Equatorial Guinea
- Lebanon
How they compare
Equatorial Guinea currently reports 38.1 against 38.1 in Lebanon, a difference of 0.
Across all 30 years both countries report, Lebanon has been ahead every year.
Equatorial Guinea ranks 96th and Lebanon ranks 96th of 194 countries.
Lebanon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Equatorial Guinea | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 37.14 | 38.02 | 0.88 | Lebanon |
| 2000s | 38.44 | 39.42 | 0.98 | Lebanon |
| 2010s | 38.59 | 38.8 | 0.21 | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in adults aged 30-79, Equatorial Guinea or Lebanon?
- Equatorial Guinea, at 38.1 against 38.1 in Lebanon as of 2019.
- What is the difference in prevalence rate of hypertension in adults aged 30-79 between Equatorial Guinea and Lebanon?
- 0, with Equatorial Guinea ahead.
- How many years of comparable data are there for Equatorial Guinea and Lebanon?
- 30 years are reported by both, from 1990 to 2019.
- How do Equatorial Guinea and Lebanon rank globally for prevalence rate of hypertension in adults aged 30-79?
- Equatorial Guinea ranks 96th and Lebanon ranks 96th of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in adults aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of the population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.